Biochemical Journal 2016, volume 473, issue 19, pages 3355–3369; DOI: 10.1042/BCJ20160558

A Competing Interests statement indicating that the author Sunil Sharma has an equity interest in Salarius Pharmaceuticals, which holds the license to the LSD1 inhibitors intellectual property, was not included in the published article.